AI Can Speed Drug Discovery. But Is It Really Better Than a Human?

The project is just one example of the pharmaceutical industry’s embrace of AI to turbocharge drug development. Genentech’s Swiss parent, Roche Holding AG, has some of the most ambitious plans, including building its own generative AI tool, dubbed . The goal is not just to move faster but also to answer questions that couldn’t be answered before, Regev says. She describes the AI boost as like being a scientist “on steroids.”